Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
May 24 2021 - 8:30AM
Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage
biotechnology company focused on Alzheimer’s disease, today
announced it will participate in a Q&A panel discussion focused
on innovative treatment approaches for Alzheimer’s disease. Jason
McCarthy, PhD, Head of Biotechnology Research Group and Senior
Managing Director, Maxim Group, will moderate the discussion on
Wednesday, May 26th at 11:00am Eastern time.
Remi Barbier, President & CEO, will
participate for Cassava Sciences. To RSVP for the Maxim
Group/M-Vest Virtual Panel on Alzheimer’s Disease, please visit the
event website, here.
About Alzheimer’s
Disease Alzheimer’s disease is a progressive brain
disorder that destroys memory and thinking skills. Currently, there
are no drug therapies to halt Alzheimer’s disease, much less
reverse its course. As of 2020, there were approximately 50 million
people worldwide living with dementia, a figure expected to
increase to 150 million by 2050.1 The annual global cost of
dementia is now above $1 trillion, according to
Alzheimer’s Disease International, a charitable organization.
About Cassava Sciences,
Inc.Cassava Sciences’ mission is to discover and develop
innovations for chronic, neurodegenerative conditions. Over the
past 10 years, Cassava Sciences has combined state-of-the-art
technology with new insights in neurobiology to develop novel
solutions for Alzheimer’s disease. For more information, please
visit: https://www.CassavaSciences.com
About Maxim Group/M-VestMaxim
Group LLC is a full-service investment banking, securities and
wealth management firm headquartered in New York. M-Vest serves as
a digital marketplace, focused on providing investors with the
latest information on innovative emerging growth companies.
For More Information Contact:
Eric Schoen, Chief Financial
Officereschoen@CassavaSciences.com(512) 501-2450
1 Alzheimer's Disease International, Dementia Statistics,
available on-line and accessed May 23, 2021.
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cassava Sciences (NASDAQ:SAVA)
Historical Stock Chart
From Sep 2023 to Sep 2024